International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 660-664 doi: 10.5281/zenodo.16880192
Original Article
Microbiology of Fournier’s Gangrene: Diabetes vs. Non-Diabetes
 ,
 ,
 ,
Published
Aug. 14, 2025
Abstract

Background: Fournier’s gangrene (FG) is a rapidly progressive necrotizing fasciitis of the perineum and genital region. Diabetes mellitus is a major predisposing factor that may influence microbial spectrum and antibiotic resistance patterns.

Objective: To compare the clinical profile, microbial spectrum, and antimicrobial resistance in diabetic and non-diabetic FG patients.

Methods: In this prospective observational study at a tertiary care hospital, patients diagnosed with FG over 24 months were categorized into diabetic and non-diabetic groups. Clinical features, risk factors, microbial isolates, and antibiotic susceptibility patterns were recorded. Comparisons were made using appropriate statistical tests.

Results: Of 50 patients, 32 (64%) were diabetic. Mean age was 50.6 years; males comprised 68%. Local trauma (42%) was the most common predisposing factor. Clinical features, including erythema, tenderness, and edema, were common in both groups without significant difference. Polymicrobial infection occurred in 72% of cases. Streptococcus spp. predominated overall, with higher prevalence in diabetics. Pseudomonas spp. were significantly more common in diabetics (p = 0.022), while Enterobacter spp. were seen only in non-diabetics (p = 0.025). High rates of ESBL production and carbapenem resistance were observed among Gram-negative isolates. MRSA was detected in 8 cases.

Conclusion: Clinical presentation of FG is similar in diabetics and non-diabetics; however, microbial profiles differ, with diabetics showing higher Pseudomonas isolation. Rising multidrug resistance warrants early, broad-spectrum empiric therapy with subsequent de-escalation

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
2555 Views
188 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved